4
Changes in Ownership
Solid Biosciences Inc. Filed Acc 0001193125-26-034080
Chief Operating Officer sold 37,771 shares at $6.44 ($243,128)
- Chief Operating Officer acquired 121,616 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Howton David T Chief Operating Officer | 2026-01-29 | Option exercise 10b5-1 | +79,341 | 112,249 | D | ||
| Howton David T Chief Operating Officer | 2026-01-31 | Option exercise 10b5-1 | +42,275 | 154,254 | D | ||
| Howton David T Chief Operating Officer | 2026-02-02 | Sale 10b5-1 | −37,771 | $6.44 | $243,128 | 116,753 | D |
| Derivatives | |||||||
| Howton David T Chief Operating Officer | 2026-01-29 | Option exercise · Performance Stock Units 10b5-1 | −79,341 | 0 | D | ||
| Howton David T Chief Operating Officer | 2026-01-29 | Grant or award · Employee Stock Option (Right to Buy) 10b5-1 | +210,200 | 210,200 | D | ||
| Howton David T Chief Operating Officer | 2026-01-29 | Grant or award · Restricted Stock Units 10b5-1 | +105,100 | 105,100 | D | ||
| Howton David T Chief Operating Officer | 2026-01-31 | Option exercise · Restricted Stock Units 10b5-1 | −42,275 | 126,825 | D | ||
| Open-market sales · 37,771 sh · avg $6.44 · $243,128 | |||||||
Loading xslF345X05/ownership.xml…